USA News
  2020-02-03
AtriCure to Participate at the SVB Leerink 9th Annual Global Healthcare Conference
MASON, Ohio --(BUSINESS WIRE)--Feb. 3, 2020-- AtriCure, Inc. ( Nasdaq: ATRC ), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that the company will be participating in the upcoming SVB Leerink 9 th Annual Global
© 2021 Atricure, Inc. All Rights Reserved.